Interactions between Xenobiotics and DME (XEOTIC)
|
Amino Acid(s), Peptide(s) or Protein(s) |
Peptide |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
Lariatins A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03807
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Lariatins A inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis |
[1] |
Lariatins B |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03808
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Lariatins B inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis |
[1] |
Mutacin II mutacin H-29B |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO04156
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Mutacin II mutacin H-29B inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis |
[2] |
Sapecin defensin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO04904
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Sapecin defensin inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis (MIC = 78 ug/ml) |
[3], [4] |
Sarcotoxin-1D |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO04909
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Sarcotoxin-1D inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis |
[3] |
Natural Product(s), Extract(s) or Medicine(s) |
Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 4 Xenobiotics
|
Parinari curatellifolia DCM extract |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03084
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Plant Extract |
DME Modulation |
Parinari curatellifolia DCM extract inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis |
[5] |
Parinari curatellifolia ethyl acetate extract |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03353
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Plant Extract |
DME Modulation |
Parinari curatellifolia ethyl acetate extract inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis |
[5] |
Parinari curatellifolia hexane extract |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03553
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Plant Extract |
DME Modulation |
Parinari curatellifolia hexane extract inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis |
[5] |
Parinari curatellifolia methanol extract |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO04085
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Plant Extract |
DME Modulation |
Parinari curatellifolia methanol extract inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis |
[5] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Acetylcysteine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00110
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetylcysteine inhibits the drug-metabolizing activity of Cytochrome P450 125A3 (cyp125) from Mycolicibacterium smegmatis |
[6] |
|
|
|
|
|
|